Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Letter]
Leticia Orsatti, Josep Fortea, Manuel Quaresma Boehringer Ingelheim International GmbH, Ingelheim, GermanyWe read with interest the study by Abe et al on the clinical utility of nintedanib in patients with severe idiopathic pulmonary fibrosis (IPF).1 Based on the retrospective fol...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-04-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/letter-utility-of-nintedanib-for-severe-idiopathic-pulmonary-fibr-peer-reviewed-article-DDDT |